Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

N. Von Bubnoff; C. Rummelt; H. Menzel; M. Sigl; C. Peschel; J. Duyster

doi:10.1038/leu.2010.122

Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

N. Von Bubnoff, C. Rummelt, H. Menzel, M. Sigl, C. Peschel, J. Duyster

Default

Technical University of Munich

Research output: Contribution to journal › Letter › peer-review

18 Scopus citations

Original language	English
Pages (from-to)	1523-1525
Number of pages	3
Journal	Leukemia
Volume	24
Issue number	8
DOIs	https://doi.org/10.1038/leu.2010.122
State	Published - Aug 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2010.122

Cite this

@article{20fe7f50d7314eb89bf79c6bd4219c1b,

title = "Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib",

author = "\{Von Bubnoff\}, N. and C. Rummelt and H. Menzel and M. Sigl and C. Peschel and J. Duyster",

note = "Funding Information: Institut National du Cancer. This work was supported by grants from the Ligue Nationale Contre le Cancer ({\'e}quipe labelis{\'e}e 2009). This letter is dedicated to Sabrina Dupont whose work greatly contributed to the discovery of TET2 mutations in MPNs. Funding Information: This work was supported by Bundesministerium f{\"u}r Bildung und Forschung grant NGFNplus 01GS0878.",

year = "2010",

month = aug,

doi = "10.1038/leu.2010.122",

language = "English",

volume = "24",

pages = "1523--1525",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

AU - Von Bubnoff, N.

AU - Rummelt, C.

AU - Menzel, H.

AU - Sigl, M.

AU - Peschel, C.

AU - Duyster, J.

N1 - Funding Information: Institut National du Cancer. This work was supported by grants from the Ligue Nationale Contre le Cancer (équipe labelisée 2009). This letter is dedicated to Sabrina Dupont whose work greatly contributed to the discovery of TET2 mutations in MPNs. Funding Information: This work was supported by Bundesministerium für Bildung und Forschung grant NGFNplus 01GS0878.

PY - 2010/8

Y1 - 2010/8

UR - https://www.scopus.com/pages/publications/77955710421

U2 - 10.1038/leu.2010.122

DO - 10.1038/leu.2010.122

M3 - Letter

C2 - 20520641

AN - SCOPUS:77955710421

SN - 0887-6924

VL - 24

SP - 1523

EP - 1525

JO - Leukemia

JF - Leukemia

IS - 8

ER -

Identification of a secondary FLT3/A848P mutation in a patient with FLT3-ITD-positive blast phase CMML and response to sunitinib and sorafenib

UN SDGs

Access to Document

Other files and links

Cite this